Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations

Recro Pharma, Inc. to acquire San Diego-Based

Announced Aug 13, 2021 · Announced · Private target

Deal value$50M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock

Transaction

Acquirer
Recro Pharma, Inc.
Target
San Diego-Based
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Announced

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Pharmaceutical Preparations
Sources
  • 8-K (EX-99.2) · Aug 13, 2021

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.